Epoxyeicosatrienoic acids and endothelium-dependent responses

Pflugers Archiv European Journal of Physiology

Volumn 459, Issue 6, 2010, Pages 881-895

  Campbell, William B ^a   Fleming, Ingrid ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Arachidonic acid; Cytochrome P450; Endothelial cells; Potassium channels; Smooth muscle cells

Indexed keywords

ACETYLCHOLINE; ARACHIDONIC ACID; BRADYKININ; CALCIUM ACTIVATED POTASSIUM CHANNEL; CYTOCHROME P450; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; EPOXYICOSATRIENOIC ACID; GAP JUNCTION PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; LIPOXYGENASE; POTASSIUM CHANNEL; POTASSIUM ION; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE; TRANSIENT RECEPTOR POTENTIAL CHANNEL;

BLOOD FLOW; BLOOD VESSEL TONE; DOWN REGULATION; ENDOTHELIUM CELL; ENZYME ACTIVATION; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; GAP JUNCTION; HEMOSTASIS; HUMAN; HYPERPOLARIZATION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SHEAR STRESS; SMOOTH MUSCLE FIBER; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

8,11,14-EICOSATRIENOIC ACID; ANIMALS; ARACHIDONIC ACID; ARTERIES; BIOLOGICAL FACTORS; CYTOCHROME P-450 ENZYME SYSTEM; EICOSANOIDS; ENDOTHELIUM, VASCULAR; ENDOTHELIUM-DEPENDENT RELAXING FACTORS; EPOXIDE HYDROLASES; HEME OXYGENASE (DECYCLIZING); HUMANS; MUSCLE, SMOOTH, VASCULAR; POTASSIUM CHANNEL BLOCKERS; VASODILATION;

EID: 77952889496     PISSN: 00316768     EISSN: 14322013     Source Type: Journal    
DOI: 10.1007/s00424-010-0804-6     Document Type: Review

References (113)

1. RF Furchgott PM Vanhoutte 1989 Endothelium-derived relaxing and contracting factors FASEB J 3 2007 2018 2545495
2. RF Furchgott JW Zawadzki 1980 The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine Nature 288 373 376 6253831
3. RA Cohen PM Vanhoutte 1995 Endothelium-dependent hyperpolarization: beyond nitric oxide and cyclic GMP Circulation 92 3337 3349 7586323
4. I Fleming R Busse 2006 Endothelium-derived epoxyeicosatrienoic acids and vascular function Hypertension 47 629 633 16490839
5. M Feletou PM Vanhoutte 2006 Endothelium-derived hyperpolaizing factor. Where are we now? Arterioscler Thromb Vasc Biol 26 1215 1225 16543495
6. M Rosolowsky WB Campbell 1993 Role of PGI2 and EETs in the relaxation of bovine coronary arteries to arachidonic acid Am J Physiol 264 H327 H335 8447448
7. M Rosolowsky WB Campbell 1996 Synthesis of hydroxyeicosatetraenoic acids (HETEs) and epoxyeicosatrienoic acids (EETs) by cultured bovine coronary artery endothelial cells Biochim Biophys Acta 1299 267 277 8555273
8. WB Campbell JR Falck 2007 Arachidonic acid metabolites as endothelium-derived hyperpolarizing factors Hypertension 49 590 596 17200437
9. Y Chawengsub KM Gauthier WB Campbell 2009 Role of arachidonic acid lipoxygenase metabolites in the regulation of vascular tone Am J Physiol 297 H495 H507
10. PM Zygmunt G Edwards AH Weston SC Davis ED Hogestatt 1996 Effects of cytochrome P450 inhibitors on EDHF-mediated relaxation in the rat hepatic artery Brit J Pharmacol 118 1147 1152 (Pubitemid 26235612)
11. M Fukao Y Hattori M Kanno I Sakuma A Kitabatake 1997 Evidence against a role of cytochrome P450-derived arachidonic acid metabolites in endothelium-dependent hyperpolarization by acetylcholine in rat isolated mesenteric artery Brit J Pharmacol 120 439 446
12. G Edwards KA Dora MJ Gardener CJ Garland AH Weston 1998 K is an endothelium-derived hyperpolarizing factor in rat arteries Nature 396 269 272 9834033 (Pubitemid 28541391)
13. T Matoba H Shimokawa M Nakashima Y Hirakawa Y Mukai K Hirano H Kandaide A Takeshita 2000 Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice J Clin Invest 106 1521 1530 11120759
14. SD Chauhan H Nilsson A Ahluwalia AJ Hobbs 2003 Release of C-type natriuretic peptide accounts for the biological activity of endothelium-derived hyperpolarizing factor Proc Natl Acad Sci USA 100 1426 1431 12552127
15. WW Batenburg IM Garrelds JP van Kats PR Saxena AHJ Danser 2004 Mediators of bradykinin-induced vasorelaxation in human coronary microarteries Hypertension 43 488 492 14691197
16. J Capdevila N Chacos J Werringloer RA Prough RW Estabrook 1981 Liver microsomal cytochrome P450 and the oxidative metabolism of archidonic acid Proc Natl Acad Sci USA 78 5362 5366 6795631 (Pubitemid 12248586)
17. DC Zeldin 2001 Epoxygenase pathways of arachidonic acid metabolism J Biol Chem 276 36059 36062 11451964
18. JH-C Lin Y Kobari MB Stemerman KA Pritchard 1996 Human umbilical vein endothelial cells express P450 2C8 mRNA: cloning of endothelial P450 epoxygenase Endothelium 4 219 229
19. K Node Y Huo X Ruan B Yang M Spiecker K Ley D Zeldin J Liao 1999 Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids Science 285 1276 1279 10455056
20. DC Zeldin RN Dubois JR Falck JH Capdevila 1995 Molecular cloning, expression and characterization of an endogenous human cytochrome P450 arachidonic acid epoxygenase isoform Arch Biochem Biophys 322 7686
21. S Wu CR Moomaw KB Tomer JR Falck DC Zeldin 1996 Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart J Biol Chem 271 3460 3468 8631948
22. WB Campbell D Gebremedhin PF Pratt DR Harder 1996 Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors Circ Res 78 415 423 8593700
23. K Nithipatikom PF Pratt WB Campbell 2000 Determination of EETs using microbore liquid chromatography with fluorescence detection Am J Physiol 279 H857 H862
24. B Fissllthaler R Popp UR Michaelis L Kiss I Fleming R Busse 2001 Cyclic stretch enhances the expression and activity of coronary endothelium-derived hyperpolarizing factor synthase Hypertension 38 1427 1432
25. A Huang D Sun A Jacobson MA Carroll JR Falck G Kaley 2005 Epoxyeicosatrienoic acids are released to mediate shear stress-dependent hyperpolarization of arteriolar smooth muscle Circ Res 96 376 383 15637296
26. KM Gauthier EM Edwards JR Falck DS Reddy WB Campbell 2005 14, 15-Epoxyeicosatrienoic acid represents a transferable endothelium-dependent relaxing factor in bovine coronary arteries Hypertension 45 666 671 15699460
27. B Fisslthaler R Popp L Kiss M Potente DR Harder I Fleming R Busse 1999 Cytochrome P450 2C is an EDHF synthase in coronary arteries Nature 401 493 497 10519554 (Pubitemid 29470209)
28. S-S Bolz B Fissllthaler S Pieperhoff C De Wit I Fleming R Busse U Pohl 2000 Antisense oligonucleotides against cytochrome P450 2C8 attenuates EDHF-mediated Ca2+ changes and dilation in isolated resistance arteries FASEB J 14 255 260 10657982
29. WB Campbell BB Holmes JR Falck JH Capdevila KM Gauthier 2006 Adenoviral expression of cytochrome P450 epoxygenase in coronary smooth muscle cells: regulation of potassium channels by endogenous 14(S), 15(R)-EET Am J Physiol 290 H64 H71
30. AA Spector X Fang GD Snyder NL Weintraub 2004 Epoxyeicosatrienoic acids (EETs): metabolism and biochemical function Prog Lipid Res 43 55 90 14636671
31. AA Spector AW Norris 2007 Action of epoxyeicosatrienoic acids on cellular function Am J Physiol 292 C996 C1012
32. WB Campbell C Deeter KM Gauthier RH Ingraham JR Falck P-L Li 2002 14, 15-Dihydroxyeicosatrienoic acid relaxes bovine coronary arteries by activation of KCa channels Am J Physiol 282 H1656 H1664
33. B Kerseru E Barbosa-Sicard R Popp B Fissllthaler A Dietrich T Gudermann BD Hammock JR Falck N Weissmannn R Busse I Fleming 2008 Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstriction response FASEB J 22 4306 4315
34. B Kerseru E Barbosa-Sicard RT Schermuly H Tanaka BD Hammock M Weissman B Fissllthaler I Fleming 2010 Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion versus inhibiton Cardiovas Res 85 232 240
35. P Pokreisz I Fleming L Kiss E Barbosa-Sicard B Fissllthaler JR Falck BD Hammock I-H Kim Z Szelid P Vermeersch H Gillijns M Pellens F Grimminger AJ van Zonneveld D Collen R Busse S Janssens 2006 Cytochrome P450 epoxygenase gene function in hypoxic pulmonary vasoconstriction and pulmonary vascular remodeling Hypertension 47 762 770 16505204
36. D Ai D Guo H Tanake N Wang C Tang BD Hammock JY-J Shyy Y Zhu 2007 Angiotensin II up-regulates soluble epoxide hydrolase in vascular endothelium in vitro and in vivo Proc Nat Acad Sci USA 104 9018 9023 17495027
37. JD Imig BD Hammock 2009 Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases Nature Rev Drug Discov 8 794 805
38. O Jung RP Brandes IH Kim F Schweda R Schmidt BD Hammock I Fleming 2005 Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension Hypertension 45 759 765 15699457
39. KL Fife Y Liu KR Schmelzer H-J Tsai I-H Kim C Morisseau BD Hammock DL Kroetz 2008 Inhibition of soluble epoxie hydrolase does not protect against endotoxin-mediated hepatic inflammation J Pharmacol Exp Ther 327 707 715 18815352
40. E Barbosa-Sicard T Fromel B Kerseru RP Brandes C Morisseau BD Hammock T Braun M Kruger I Fleming 2009 Inhibition of the soluble epoxide hydrolase by tyrosine nitration J Biol Chem 284 28156 28163 19704161
41. R Popp I Fleming R Busse 1998 Pulsatile stretch in coronary arteries elicits release of endothelium-derived hyperpolarizing factor: a modulator of arterial compliance Circ Res 82 696 703 9546378
42. SL Archer FS Gragasin X Wu S Wang S McMurtry DH Kim M Platonov A Koshal K Hasimoto WB Campbell JR Falck ED Michelakis 2003 Endothelium-derived hyperpolarizing factor in human internal mammary artery is 11, 12-epoxyeicosatrienoic acid and causes relaxation by activating smooth muscle BKca channels Circulation 107 769 776 12578883
43. P Coats F Johnston J MacDonald JJV McMurray C Hillier 2001 Endothelium-derived hyperpolarizing factor: identification and mechanism of action in human subcutaenous resistance arteries Circulation 103 1702 1708 11274000
44. H Miura RE Wachtel Y Liu FR Loberiza Jr T Saito M Miura DD Gutterman 2001 Flow-induced dilation of human coronary arterioles: important role of Ca2+-activated K+ channels Circulation 103 1992 1998 11306529
45. M Hecker AT Bara J Bauersachs R Busse 1994 Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals J Physiol 481 407 414 7738833
46. R Busse G Edwards M Feletou I Fleming PM Vanhoutte AH Weston 2002 EDHF: bringing the concepts together TiPS 23 374 380 12377579
47. IN McSherry SL Sandow WB Campbell JR Falck MA Hill KA Dora 2006 A role for heterocellular coupling and EETs in dilation of rat cremaster arteries Microcirculation 13 119 130 16459325
48. AH Weston M Feletou PM Vanhoutte JR Falck WB Campbell G Edwards 2005 Bradykinin-induced, endothelium-dependent responses in porcine coronary arteries: involvement of potassium channel activation and epoxyeicosatrienoic acids Brit J Pharmacol 145 775 784
49. S Earley T Pauyo R Drapp MJ Tavares W Liedtke JE Brayden 2009 TRPV4-dependent dilation of peripheral resistance arteries influences arterial pressure Am J Physiol 297 H1096 H1102
50. KM Gauthier C Deeter UM Krishna YK Reddy M Bondlela JR Falck WB Campbell 2002 14, 15-Epoxyeicosa-5(Z)-enoic acid: a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries Circ Res 90 1028 1036 12016270
51. WB Campbell DR Harder 1999 Endothelium-derived hyperpolarizing factors and vascular cytochrome P450 metabolites of arachidonic acid in the regulation of tone Circ Res 84 484 488 10066684
52. PF Pratt P Li CJ Hillard J Kurian WB Campbell 2001 Endothelium- independent, ouabain-sensitive relaxation of bovine coronary arteries by EETs Am J Physiol 280 H1113 H1121
53. D Gebremedhin Y-H Ma JR Falck RJ Roman M VanRollins DR Harder 1992 Mechanism of action of cerebral epoxyeicosatrienoic acids on cerebral arterial smooth muscle Am J Physiol 263 H519 H525 1510149
54. P-L Li WB Campbell 1997 Epoxyeicosatrienoic acids activate potassium channels in coronary smooth muscle through guanine nucleotide binding protein Circ Res 80 877 884 9168791
55. R Popp J Bauersachs M Hecker I Fleming R Busse 1996 A transferable, beta-naphthoflavone-inducible, hyperpolarizing factor is synthesized by native and cultured porcine coronary endothelial cells J Physiol 497 699 709 9003555
56. D Gebremedhin DR Harder PF Pratt WB Campbell 1998 Bioassay of an endothelium-derived hyperpolarizing factor from bovine coronary arteries: role of a cytochrome P450 metabolite J Vasc Res 35 274 284 9701712
57. MP Burnham R Bychkov M Feletou GR Richards PM Vanhoutte AH Weston G Edwards 2002 Characterization of an apamn-sensitive small-conductance Ca2+-activated K+ channel in porcine coronary artery endothelium: relevance to EDHF Brit J Pharmacol 135 1133 1143 (Pubitemid 34259113)
58. R Bychkov MP Burnham GR Richards G Edwards AH Weston M Feletou PM Vanhoutte 2002 Characterization of a charybdotoxin-sensitive intermediate conductance Ca2+-activated K+ channel in porcine coronary endothelium: relevance to EDHF Brit J Pharmacol 137 1346 1354 (Pubitemid 36071753)
59. AT Chaytor PEM Martin DH Edwards TM Griffith 2001 Gap junctional communication underpins EDHF-type relaxations evoked by acetylcholine in the rat hepatic artery Am J Physiol 280 H2441 H2450
60. SL Sandow CE Hill 2000 Incidence of myoendothelial gap junctions in the proximal and distal mesenteric arteries of the rat is suggestive of a role in endothelium-derived hyperpolarizing factor-mediated responses Circ Res 86 341 346 10679487
61. R Popp RP Brandes G Ott R Busse I Fleming 2002 Dynamic modulation of interendothelial gap junctional communication by 11,12-epoxyeicosatrienoic acid Circ Res 90 800 806 11964373
62. I Fleming A Rueben R Popp B Fissllthaler S Schrodt A Sander J Haendeler JR Falck C Morisseau BD Hammock R Busse 2007 Epoxyeicosatrienoic acids regulate Trp-channel-dependent Ca signaling and hyperpolariztion in endothelial cells Arterio Thromb Vasc Biol 27 2612 2618
63. J Vriens G Owsianik B Fissllthaler M Suzuki A Janssens T Voets C Morisseau BD Hammock I Fleming R Busse B Nilius 2005 Modulation of the Ca permeable cation channel TRPV4 by cytochrome P450 epoxygenases in vascular endothelium Circ Res 97 908 915 16179585
64. J Petersson PM Zygmunt P Jonsson ED Hogestatt 1998 Characterization of endothelium-dependent relaxations in guinea pig basilar ratery-effect of hypoxia and role of cytochrome P450 monooxygenase J Vas Res 35 285 294
65. T Chataigneau M Feletou J Duhault PM Vanhoutte 1998 Epoxyeicosatrienoic acids, potassium channel blockers and endothelium-dependent hyperpolarizations in the guinea pig carotid artery Brit J Pharmacol 123 574 580
66. BT Larsen WB Campbell DD Gutterman 2007 Beyond vasodilation: non-vasomotor roles of epoxyeicosatrienoic acids in the cardiovascular system TIPS 28 32 38 17150260
67. I Fleming 2008 Vascular cytochrome P450 enzymes: physiology and pathophysiology TCM 18 20 25 18206805
68. M Rosolowsky JR Falck JT Willerson WB Campbell 1990 Synthesis of lipoxygenase and epoxygenase products of arachidonic acid by normal and stenosed canine coronary arteries Circ Res 66 608 621 2106399
69. BT Larsen H Miura OA Hatoum WB Campbell BD Hammock DC Zeldin JR Falck DD Gutterman 2005 Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BKca channels: implications for soluble epoxide hydrolase inhibition Am J Physiol 290 H491 H499
70. JR Falck UM Krishna YK Reddy PS Kumar KM Reddy SB Hittner C Deeter KK Sharma KM Gauthier WB Campbell 2003 Comparison of the vasodilatory properties of 14, 15-EET analogs: structural requirements for dilation Am J Physiol 284 H337 H349
71. MA Carroll M Schwartzman J Capdevila JR Falck JC McGiff 1987 Vasoactivity of arachidonic acid epoxides Europ J Pharmacol 138 281 283
72. A Zou JT Fleming JR Falck ER Jacobs D Gebremedhin DR Harder RJ Roman 1996 Stereospecific effects of epoxyeicosatrienoic acids on renal vascular tone and K+-channel activity Am J Physiol 270 F822 F832 8928844
73. JD Imig LG Navar RJ Roman KK Reddy JR Falck 1996 Actions of epoxygenase metabolites on the preglomerular vasculature J Am Soc Nephrol 7 2364 2370 8959626
74. CL Oltman NL Weintraub M VanRollins KC Dellsperger 1998 Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation Circ Res 83 932 939 9797342
75. Y Hayabuchi Y Nakaya S Matsuoka Y Kuroda 1998 Endothelium-derived hyperpolarizing factor activates Ca2+-activated K+ channels in porcine coronary artery smooth muscle cells J Cardiovasc Pharmacol 32 642 649 9781934 (Pubitemid 28440967)
76. M Fukao HS Mason JL Kenyon B Horowitz KD Keef 2001 Regulation of BKCa channels expressed in human embryonic kidney 293 cells by epoxyeicosatrienoic acid Molec Pharmacol 59 16 23
77. K Node X-L Ruan J Dai S-X Yang L Graham DC Zeldin JK Liao 2001 Activation of Gas mediates induction of tissue-type plasminogen activator gene transcription by epoxyeicosatrienoic acids J Biol Chem 276 15983 15989 11279071
78. P-L Li C-L Chen R Bortell WB Campbell 1999 11,12-Epoxyeicosatrienoic acid stimulates endogenous mono-ADP-ribosylation in bovine coronary arterial smooth muscle Circ Res 85 349 356 10455063
79. J Sun X-X Sui A Bradbury DC Zeldin MS Conte JK Liao 2002 Inhibition of vascular smooth muscle cell migration by cytochrome P450 epoxygenase-derived eicosanoids Circ Res 90 1020 1027 12016269
80. C Dimitropoulou L West MB Field RE White LM Reddy JR Falck JD Imig 2007 Protein phosphatase 2A and Ca-activated K channels contribute to 11, 12-epoxyeicosatrienoic acid analog mediated mesenteric arterial dilation Prostag and Other Lipid Mediat 83 50 61
81. GD Snyder UM Krishna JR Falck AA Spector 2002 Evidence for a membrane site of action for 14, 15-EET on expression of aromatase in vascular smooth muscle Am J Physiol 283 H1936 H1942
82. PY Wong KT Lin YT Yan D Ahern J Iles SY Shen RK Bhatt JR Falck 1993 14(R),15(S)-Epoxyeicosatrienoic acid receptor in guinea pig mononuclear cell membranes J Lipid Mediat Cell Signal 6 199 208
83. PY-K Wong P-S Lai JR Falck 2000 Mechanism and signal transduction of 14(R), 15 (S)-epoxyeicosatrienoic acid (14, 15-EET) binding in guinea pig monocytes Prostag Other Lipid Med 62 321 333
84. PY-K Wong P-S Lai S-Y Shen YY Belosludtsev JR Falck 1997 Post-receptor signal transduction and regulation of 14(R), 15(S)-epoxyeicosatrienoic acid (14, 15-EET) binding in U-937 cells J Lipid Med Cell Signal 16 155 169
85. W Yang VR Tuniki S Anjaiah JR Falck CJ Hillard WB Campbell 2008 Characterization of epoxyeicosatrienoic acid binding site in U937 membranes using a novel radiolabeled agonist, 20-125I-14,15-epoxyeicosa-8(Z)-enoic acid J Pharmacol Exp Ther 324 1019 1027 18171909
86. B Inceoglu KR Schmelzer C Morisseau SL Jinks BD Hammock 2007 Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs) Prostag and Other Lipid Mediat 82 42 49
87. Y Chen JR Falck VR Tuniki WB Campbell 2009 20-125Iodo-14, 15-epoxyeicosa-5Z-enoic acid: a high affinity radioligand used to characterize the epoxyeicosatrienoic acid antagonist binding site J Pharmacol Exp Ther 331 1137 1145 19762546
88. KM Gauthier SG Jagadeesh JR Falck WB Campbell 2003 14,15-Epoxyeicosa-5(Z) -enoic-mSI: a 14,15- and 5,6-EET antagonist in bovine coronary arteries Hypertension 42 555 561 12953017
89. X Yao CJ Garland 2005 Recent developments in vascular endothelial cell transient receptor potential channels Circ Res 97 853 863 16254217
90. H Watanabe J Viriens J Prenin G Droogmans T Voets B Nilius 2003 Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels Nature 424 434 438 12879072
91. S Earley TJ Heppner MT Nelson JE Brayden 2005 TRPV4 forms a novel Ca2+ signaling complex with ryanodine receptors and BK Ca channels Circ Res 97 1270 1279 16269659
92. AE Loot R Popp B Fissllthaler J Vriens B Nilius I Fleming 2008 Role of cytochrome P450-dependent transient receptor potential V4 activation in flow-induced vasodilation Cardiovas Res 80 445 452
93. MT Alonso J Alvarez M Montero A Sanchez J Garcia-Sancho 1991 Agonist-induced Ca influx into human platelets is secondary to emptying of intracellular Ca stores Biochem J 280 783 789 1764041
94. J Alvarez M Montero J Garcia-Sancho 1991 Cytochrome P450 may link intercellular lCa stores with plasma membrane Ca influx Biochem J 274 193 197 2001232
95. B Nilius J Vriens J Prenen G Droogmans T Voets 2004 TRPV4 calcium entry channel: a paradigm for gating diversity Am J Physiol 286 C195 C205
96. DJ Behm A Ogbonna C Wu CL Burns-Kurtis SA Douglas 2009 Epoxyeicosatrienoic acids function as selective, endogenous antagonists of native thromboxane receptors: identification of a novel mechanism of vasodilation J Pharmacol Exp Ther 328 231 239 18836067
97. D Ye W Zhou H-C Lee 2005 Activation of rat mesenteric arterial Katp channels by 11,12-epoxyeicosatrienoic acid Am J Physiol 288 H358 H364
98. D Ye W Zhou T Lu SG Jagadeesh JR Falck H-C Lee 2006 Mechanism of rat mesenteric arterial KATP channel activation by 14,15-epoxyeicosatrienoic acid Am J Physiol 290 J1326 H1336
99. D Sacerdoti M Bolognesi M DiPascoli A Gatta JC McGiff ML Schwartzman NG Abraham 2006 Rat mesenteric arterial dilator response to 11,12- epoxyeicosatrienoic acid is mediated by activating heme oxygenase Am J Physiol 291 H1999 H2002
100. JH Jaggar A Li H Parfenova J Liu ES Umstot AM Dopico CW Leffler 2005 Heme is a carbon monoxide receptor for large-conducatance C-activated K channels Circ Res 97 805 812 16166559
101. MD Widmann NL Weintraub JL Fudge LA Brooks KC Dellsperger 1998 Cytochrome P-450 pathway in acetylcholine-induced canine coronary microvascular vasodilation in vivo Am J Physiol 274 H283 H289 9458878
102. Y Nishikawa DW Stepp WM Chilian 1999 In vivo location and mechanism of EDHF-mediated vasodilation in canine coronary microcirculation Am J Physiol 277 H1252 H1259 10484447
103. Y Nishikawa DW Stepp WM Chilian 2000 Nitric oxide exerts feedback inhibition on EDHF-induced coronary arteriolar dilation in vivo Am J Physiol 279 H459 H465
104. CL Oltman NL Kane JL Fudge NL Weintraub KC Dellsperger 2001 Endothelium-derived hyperpolarizing factor in coronary microcirculation: responses to arachidonic acid Am J Physiol 281 H1553 H1560
105. JPJ Halcox S Narayanan L Crames-Joyce R Mincemoyer AA Quyyumi 2001 Characterization of endothelium-derived hyperpolarizing factor in the human forearm microcirculation Am J Physiol 280 H2470 H2477
106. MLH Honing P Smits PJ Morrison TJ Rabelink 2000 Bradykinin-induced vasodilation of human forearm resistance vessels is primarily mediated by endothelium-dependent hyperpolarization Hypertension 35 1314 1318 10856283
107. J Passauer E Bussemaker G Lassing F Pistrosch J Fauler P Gross I Fleming 2003 Baseline blood flow and bradykinn-induced vasodilator responses in human forearm are insensitive to the cytochrome P450 2C9 (CYP2C9) inhibitor sulfaphenazole Clin Sci 105 513 518 12826020
108. S Taddei D Varsari A Cipriano L Ghiadoni F Glaetta F Franzoni A Magagna A Virdis A Salvetti 2006 Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in human essential hypertensive patients J Am Coll Cardiol 48 508 515 16875977
109. AJ Donato I Eskurza KL Jablonski LB Gano GL Pierce DR Seals 2008 Cytochrome P450 2C9 signaling does not contribute to age-associated vascular endothelial dysfunction in humans J Appl Physiol 105 1359 1363 18669935
110. D Fisher U Landmesser S Spiekermann D Hilfiker-Kleiner M Hospely M Muller R Busse I Fleming H Drexler 2007 Cytochrome P450 2C9 is involved in flow-dependent vasodilation of peripheral conduit arteries in healthy subjects and patients with chronic heart failure Europ J Heart Failure 9 770 775
111. C Marques-Soares S Dijols A-C Macherey MR Wester EF Johnson PM Dansette D Mansuy 2003 Sulfaphenazole derivatives as tools for comparing cytochrome P450 2C5 and human cytochrome P450 2Cs Biochemistry 42 6363 6369 12767217
112. I Fleming UR Michaelis D Bredenkotter B Fisslthaler F Dehghani RP Brandes R Busse 2001 Endothelium-derived hyperpolarizing factor synthase (cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries Circ Res 88 44 51 11139472
113. S Fichtlscherer S Dimmeler S Breuer R Busse AM Zeiher I Fleming 2004 Inhibition of cytochrome P450 2C9 improves endothelium-dependent nitric oxide-mediated vasodilation in patients with coronary artery disease Circulation 109 178 183 14662709